These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23634817)

  • 1. Synthetic anti-lipopolysaccharide peptides and hepatitis C virus infection.
    Habersetzer F; Leboeuf C; Doffoël M; Zeisel MB; Baumert TF
    Expert Opin Investig Drugs; 2013 Jul; 22(7):853-62. PubMed ID: 23634817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.
    Krepstakies M; Lucifora J; Nagel CH; Zeisel MB; Holstermann B; Hohenberg H; Kowalski I; Gutsmann T; Baumert TF; Brandenburg K; Hauber J; Protzer U
    J Infect Dis; 2012 Jun; 205(11):1654-64. PubMed ID: 22457281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entry inhibitors and future treatment of hepatitis C.
    Fofana I; Jilg N; Chung RT; Baumert TF
    Antiviral Res; 2014 Apr; 104():136-42. PubMed ID: 24525381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
    Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
    Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
    Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
    J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of peptides that bind hepatitis C virus envelope protein E2 and inhibit viral cellular entry from a phage-display peptide library.
    Lü X; Yao M; Zhang JM; Yang J; Lei YF; Huang XJ; Jia ZS; Ma L; Lan HY; Xu ZK; Yin W
    Int J Mol Med; 2014 May; 33(5):1312-8. PubMed ID: 24573486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential role of the heparan sulfate in the hepatitis C virus attachment.
    Heo TH
    Acta Virol; 2008; 52(1):7-15. PubMed ID: 18459830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
    Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
    Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway.
    Liu S; Wang W; Brown LE; Qiu C; Lajkiewicz N; Zhao T; Zhou J; Porco JA; Wang TT
    EBioMedicine; 2015 Nov; 2(11):1600-6. PubMed ID: 26870784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties.
    Akula SM; Pramod NP; Wang FZ; Chandran B
    Virology; 2001 Jun; 284(2):235-49. PubMed ID: 11384223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of peptides binding to HCV e2 and inhibiting viral infectivity.
    Hong HW; Lee SW; Myung H
    J Microbiol Biotechnol; 2010 Dec; 20(12):1769-71. PubMed ID: 21193836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzhydrylpiperazine compounds inhibit cholesterol-dependent cellular entry of hepatitis C virus.
    Chamoun-Emanuelli AM; Pécheur EI; Chen Z
    Antiviral Res; 2014 Sep; 109():141-8. PubMed ID: 25019406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
    Chien YJ; Chen WJ; Hsu WL; Chiou SS
    Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
    Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization.
    Schvoerer E; Moenne-Loccoz R; Murray JM; Velay A; Turek M; Fofana I; Fafi-Kremer S; Erba AC; Habersetzer F; Doffoël M; Gut JP; Donlin MJ; Tavis JE; Zeisel MB; Stoll-Keller F; Baumert TF
    J Infect Dis; 2013 Apr; 207(8):1306-15. PubMed ID: 23335805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
    Suzuki T
    Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
    Guedj J; Neumann AU
    J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant.
    Sureau C; Salisse J
    Hepatology; 2013 Mar; 57(3):985-94. PubMed ID: 23161433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes.
    Haid S; Novodomská A; Gentzsch J; Grethe C; Geuenich S; Bankwitz D; Chhatwal P; Jannack B; Hennebelle T; Bailleul F; Keppler OT; Poenisch M; Bartenschlager R; Hernandez C; Lemasson M; Rosenberg AR; Wong-Staal F; Davioud-Charvet E; Pietschmann T
    Gastroenterology; 2012 Jul; 143(1):213-22.e5. PubMed ID: 22465429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boceprevir, an NS3 protease inhibitor of HCV.
    Berman K; Kwo PY
    Clin Liver Dis; 2009 Aug; 13(3):429-39. PubMed ID: 19628159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.